Bacterin up big in early trading

Nano cap Bacterin International (BONE) zooms up 46% on 52,000 shares this morning in response to the publication of OsteoSponge results.

24 of 25 arthrodesis patients showed radiographic fusion at 6 and 12 months involving 44 out of 45 total joints.

Consensus revenue estimates for 2014 and 2015 are $32.7M and $61M, respectively. 2013 sales were $33.1M.

10 mutual funds have positions, down from 11 a year earlier.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs